Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMAB | INCY | EXAS | ||
| Company | Genmab A/S ADR | Incyte Corp | Exact Sciences Cor | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 31.79 | 102.50 | 102.35 | ||
| High | 33.22 | 105.43 | 102.55 | ||
| Low | 31.74 | 101.00 | 102.25 | ||
| Latest | 32.95 | 104.67 | 102.48 | ||
| Change | +1.62 | +2.05 | +0.13 | ||
| % Change | +5.17% | +2.00% | +0.13% | ||
| Volume | 2,282,800 | 1,569,900 | 1,965,100 | ||
| 20-Day Average Volume | 1,937,120 | 1,907,080 | 2,165,240 | ||
| Previous Close | 31.33 | 102.62 | 102.35 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 33.04 | 103.34 | 101.94 | ||
| 20-Day Raw Stochastic | 51.18% | 48.02% | 92.83% | ||
| 20-Day Relative Strength | 52.38 | 54.16 | 83.15 | ||
| Weighted Alpha | +62.70 | +54.00 | +64.88 | ||
| Today's Opinion | 80% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 64% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.72% since 01/13/26 | +1.20% since 01/13/26 | +0.22% since 01/13/26 | ||
| Low | 30.88 on 01/16/26 | 100.00 on 01/20/26 | 102.00 on 01/20/26 | ||
| High | 35.43 on 01/14/26 | 108.58 on 01/16/26 | 102.56 on 01/14/26 | ||
| 1-Month | |||||
| %Chg | +1.76% since 12/19/25 | +1.93% since 12/19/25 | +0.65% since 12/19/25 | ||
| Low | 30.35 on 12/31/25 | 97.63 on 12/29/25 | 101.44 on 12/23/25 | ||
| High | 35.43 on 01/14/26 | 112.29 on 01/07/26 | 102.56 on 01/14/26 | ||
| 3-Month | |||||
| %Chg | +9.36% since 10/21/25 | +19.90% since 10/21/25 | +61.61% since 10/21/25 | ||
| Low | 28.08 on 11/05/25 | 84.02 on 10/28/25 | 62.39 on 10/28/25 | ||
| High | 35.43 on 01/14/26 | 112.29 on 01/07/26 | 102.66 on 12/19/25 | ||
| 6-Month | |||||
| %Chg | +51.91% since 07/21/25 | +55.34% since 07/21/25 | +111.91% since 07/21/25 | ||
| Low | 21.00 on 08/11/25 | 67.20 on 07/22/25 | 38.81 on 08/07/25 | ||
| High | 35.43 on 01/14/26 | 112.29 on 01/07/26 | 102.66 on 12/19/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 20,125,890 | 20,146,664 | 19,529,402 | ||
| Shares Outstanding, K | 642,384 | 196,323 | 190,810 | ||
| Annual Sales | 3,121,270,000 | 4,241,220,000 | 2,758,870,000 | ||
| Annual Net Income | 1,137,380,000 | 32,610,000 | -1,028,860,000 | ||
| Last Quarter Sales | 1,022,000,000 | 1,365,980,000 | 850,740,000 | ||
| Last Quarter Net Income | 401,000,000 | 424,170,000 | -19,590,000 | ||
| 60-Month Beta | 0.90 | 0.82 | 1.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.65 on 11/06/25 | 2.26 on 10/28/25 | 0.24 on 11/03/25 | ||
| Latest Earnings Date | 02/11/26 | 02/09/26 | 02/18/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 15.58 | 19.96 | 539.11 | ||